The Essential Medicinal Chemistry of Curcumin

被引:1549
作者
Nelson, Kathryn M. [1 ]
Dahlin, Jayme L. [2 ]
Bisson, Jonathan [3 ]
Graham, James [3 ]
Pauli, Guido F. [3 ,4 ]
Walters, Michael A. [1 ]
机构
[1] Univ Minnesota, Inst Therapeut Discovery & Dev, Dept Med Chem, Minneapolis, MN 55414 USA
[2] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[3] Univ Illinois, Coll Pharm, Ctr Nat Product Technol, Dept Med Chem & Pharmacognosy, 833 S Wood St, Chicago, IL 60612 USA
[4] Univ Illinois, Coll Pharm, Inst Tuberculosis Res, 833 S Wood St, Chicago, IL 60612 USA
关键词
RETRACTED ARTICLE. SEE; NATURAL-PRODUCTS; ALZHEIMERS-DISEASE; ASSAY INTERFERENCE; IN-VITRO; BIOLOGICAL-ACTIVITIES; TISSUE DISTRIBUTION; ANTICANCER ACTIVITY; DRUG DISCOVERY; ORAL CURCUMIN;
D O I
10.1021/acs.jmedchem.6b00975
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
Curcumin is a constituent (up to 6%) of the traditional medicine known as turmeric. Interest in the therapeutic use of turmeric and the relative ease of isolation of curcuminoids has led to their extensive investigation. Curcumin has recently been classified as both a PAINS (pan assay interference compounds) and an IMPS (invalid metabolic panaceas) candidate. The likely false activity of curcumin in vitro and in vivo has resulted in >120 clinical trials of curcuminoids against several diseases. No double blinded, placebo controlled clinical trial of curcumin has been successful. This manuscript reviews the essential medicinal chemistry of curcumin and provides evidence that curcumin is an unstable, reactive, nonbioavailable compound and, therefore, a highly improbable lead. On the basis of this in-depth evaluation, potential new directions for research on curcuminoids are discussed.
引用
收藏
页码:1620 / 1637
页数:18
相关论文
共 161 条
[1]
Ahluwalia G. S., 1996, Patent No. [WO9609806A2, 9609806]
[2]
[Anonymous], NIH REPORTER RES POR
[3]
Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma [J].
Asai, A ;
Miyazawa, T .
LIFE SCIENCES, 2000, 67 (23) :2785-2793
[4]
Asher GN, 2013, ALTERN THER HEALTH M, V19, P20
[5]
Discovery and resupply of pharmacologically active plant-derived natural products: A review [J].
Atanasov, Atanas G. ;
Waltenberger, Birgit ;
Pferschy-Wenzig, Eva-Maria ;
Linder, Thomas ;
Wawrosch, Christoph ;
Uhrin, Pavel ;
Temml, Veronika ;
Wang, Limei ;
Schwaiger, Stefan ;
Heiss, Elke H. ;
Rollinger, Judith M. ;
Schuster, Daniela ;
Breuss, Johannes M. ;
Bochkov, Valery ;
Mihovilovic, Marko D. ;
Kopp, Brigitte ;
Bauer, Rudolf ;
Dirsch, Verena M. ;
Stuppner, Hermann .
BIOTECHNOLOGY ADVANCES, 2015, 33 (08) :1582-1614
[6]
An NMR Spectroscopic Method to Identify and Classify Thiol-Trapping Agents: Revival of Michael Acceptors for Drug Discovery? [J].
Avonto, Cristina ;
Taglialatela-Scafati, Orazio ;
Pollastro, Federica ;
Minassi, Alberto ;
Di Marzo, Vincenzo ;
De Petrocellis, Luciano ;
Appendino, Giovanni .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2011, 50 (02) :467-471
[7]
Chemical con artists foil drug discovery [J].
Baell, Jonathan ;
Walters, Michael A. .
NATURE, 2014, 513 (7519) :481-483
[8]
Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS) [J].
Baell, Jonathan B. .
JOURNAL OF NATURAL PRODUCTS, 2016, 79 (03) :616-628
[9]
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays [J].
Baell, Jonathan B. ;
Holloway, Georgina A. .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (07) :2719-2740
[10]
Molecular orbital basis for yellow curry spice curcumin's prevention of Alzheimer's disease [J].
Balasubramanian, Krishnan .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2006, 54 (10) :3512-3520